- Oral presentation
- Open Access
The clinical value of Stress Cardiac Magnetic Resonance Imaging in symptomatic patients with low to intermediate acute coronary syndrome risk
© Dong et al. 2016
- Published: 27 January 2016
- Acute Coronary Syndrome
- Cardiac Magnetic Resonance
- Diagnostic Performance
- Late Gadolinium Enhancement
- Cardiac Magnetic Resonance Image
Stress cardiac magnetic resonance (CMR) imaging has become a promising non-invasive technique that is being increasingly used to evaluate acute coronary syndrome (ACS) patients. Specifically, low- and intermediate-risk ACS patients require non-invasive imaging for risk stratification, unlike high-risk ACS patients whom may receive invasive coronary angiography (ICA) directly. This study aims to assess the diagnosis performance of stress CMR for evaluating mid- and low-risk ACS patients.
Consecutive symptomatic patients (N = 51) were prospectively enrolled from December 2013 to April 2015, with suspected ACS and with low- to intermediate-risk of disease according to the TIMI risk score. Sequential CMR, Single-Photon Emission Computed Tomography (SPECT), and invasive coronary angiography (ICA) were performed. CMR consisted of rest and adenosine triphosphate (ATP) stress perfusion, cine imaging, and late gadolinium enhancement. Semi-quantitative CMR and SPECT images were analyzed visually. We compared the diagnostic performance of stress CMR and SPECT for detecting ACS on the per-patient and per-coronary territory basis. For diagnostic performance assessment, the area under the receiver operating characteristic curve (AUC) was calculated respectively using ICA as the reference standard.
First, for detection of ACS in low-risk populations, on the per-patient level, CMR had sensitivity of 93% and specificity of 75%, and SPECT had sensitivity of 79% and specificity of 63%. The AUC of CMR was 0.879, slightly superior to that of SPECT at 0.723 (p = 0.19, n = 22). On the per-coronary territory level, CMR had sensitivity of 90% and specificity of 87%, and SPECT had sensitivity of 68% and specificity of 83%. The AUC of CMR of 0.923 was significantly superior to SPECT at 0.774 (p = 0.04, n = 66).
Second, for detection of ACS in intermediate-risk populations, on the per-patient level, CMR had sensitivity of 88% and specificity of 75%, and SPECT had sensitivity of 84% and specificity of 75%. The AUC of CMR was 0.885 and that of SPECT was 0.900 (p = 0.78, n = 29). On the per-coronary territory level, CMR had sensitivity of 73% and specificity of 78%, and SPECT had sensitivity of 73% and specificity of 76%. The AUC of CMR was 0.770, similar to SPECT of 0.785 (p = 0.75,n = 87).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.